Supplemental Figure S3 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL
<p>T cell subset analysis pre and post CAR T cell manufacturing</p>
Сохранить в:
| Главный автор: | |
|---|---|
| Другие авторы: | , , , , , , , , , , , , , , , , , , , , |
| Опубликовано: |
2025
|
| Предметы: | |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
| _version_ | 1849927633285939200 |
|---|---|
| author | Ibrahim Aldoss (15055961) |
| author2 | Samer K. Khaled (15055964) Xiuli Wang (15055967) Joycelynne Palmer (15055970) Yan Wang (15055973) Jamie R. Wagner (15055976) Mary C. Clark (15055979) Jennifer Simpson (15055982) Jinny Paul (15055985) Vibhuti Vyas (15055988) Sheng-Hsuan Chien (15055991) Anthony Stein (15055994) Vinod Pullarkat (15047900) Amandeep Salhotra (15055997) Monzr M. Al Malki (15056000) Ahmed Aribi (15056003) Karamjeet Sandhu (15056006) Sandra H. Thomas (15056009) Lihua E. Budde (15056012) Guido Marcucci (11252666) Christine E. Brown (15056015) Stephen J. Forman (15056018) |
| author2_role | author author author author author author author author author author author author author author author author author author author author author |
| author_facet | Ibrahim Aldoss (15055961) Samer K. Khaled (15055964) Xiuli Wang (15055967) Joycelynne Palmer (15055970) Yan Wang (15055973) Jamie R. Wagner (15055976) Mary C. Clark (15055979) Jennifer Simpson (15055982) Jinny Paul (15055985) Vibhuti Vyas (15055988) Sheng-Hsuan Chien (15055991) Anthony Stein (15055994) Vinod Pullarkat (15047900) Amandeep Salhotra (15055997) Monzr M. Al Malki (15056000) Ahmed Aribi (15056003) Karamjeet Sandhu (15056006) Sandra H. Thomas (15056009) Lihua E. Budde (15056012) Guido Marcucci (11252666) Christine E. Brown (15056015) Stephen J. Forman (15056018) |
| author_role | author |
| dc.creator.none.fl_str_mv | Ibrahim Aldoss (15055961) Samer K. Khaled (15055964) Xiuli Wang (15055967) Joycelynne Palmer (15055970) Yan Wang (15055973) Jamie R. Wagner (15055976) Mary C. Clark (15055979) Jennifer Simpson (15055982) Jinny Paul (15055985) Vibhuti Vyas (15055988) Sheng-Hsuan Chien (15055991) Anthony Stein (15055994) Vinod Pullarkat (15047900) Amandeep Salhotra (15055997) Monzr M. Al Malki (15056000) Ahmed Aribi (15056003) Karamjeet Sandhu (15056006) Sandra H. Thomas (15056009) Lihua E. Budde (15056012) Guido Marcucci (11252666) Christine E. Brown (15056015) Stephen J. Forman (15056018) |
| dc.date.none.fl_str_mv | 2025-11-25T13:07:03Z |
| dc.identifier.none.fl_str_mv | 10.1158/1078-0432.30707516 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/figure/Supplemental_Figure_S3_from_Favorable_Activity_and_Safety_Profile_of_Memory-Enriched_CD19-Targeted_Chimeric_Antigen_Receptor_T-Cell_Therapy_in_Adults_with_High-Risk_Relapsed_Refractory_ALL/30707516 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Immuno-oncology Clinical Research and Trials Clinical Trial Results Hematological Cancers Leukemias Immunotherapy Cellular immunotherapy Engineered/CAR T cells |
| dc.title.none.fl_str_mv | Supplemental Figure S3 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL |
| dc.type.none.fl_str_mv | Image Figure info:eu-repo/semantics/publishedVersion image |
| description | <p>T cell subset analysis pre and post CAR T cell manufacturing</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_d2815df9aef1ee4cf65d580ffc0d6418 |
| identifier_str_mv | 10.1158/1078-0432.30707516 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30707516 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Supplemental Figure S3 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALLIbrahim Aldoss (15055961)Samer K. Khaled (15055964)Xiuli Wang (15055967)Joycelynne Palmer (15055970)Yan Wang (15055973)Jamie R. Wagner (15055976)Mary C. Clark (15055979)Jennifer Simpson (15055982)Jinny Paul (15055985)Vibhuti Vyas (15055988)Sheng-Hsuan Chien (15055991)Anthony Stein (15055994)Vinod Pullarkat (15047900)Amandeep Salhotra (15055997)Monzr M. Al Malki (15056000)Ahmed Aribi (15056003)Karamjeet Sandhu (15056006)Sandra H. Thomas (15056009)Lihua E. Budde (15056012)Guido Marcucci (11252666)Christine E. Brown (15056015)Stephen J. Forman (15056018)CancerImmuno-oncologyClinical Research and TrialsClinical Trial ResultsHematological CancersLeukemiasImmunotherapyCellular immunotherapyEngineered/CAR T cells<p>T cell subset analysis pre and post CAR T cell manufacturing</p>2025-11-25T13:07:03ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1158/1078-0432.30707516https://figshare.com/articles/figure/Supplemental_Figure_S3_from_Favorable_Activity_and_Safety_Profile_of_Memory-Enriched_CD19-Targeted_Chimeric_Antigen_Receptor_T-Cell_Therapy_in_Adults_with_High-Risk_Relapsed_Refractory_ALL/30707516CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307075162025-11-25T13:07:03Z |
| spellingShingle | Supplemental Figure S3 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL Ibrahim Aldoss (15055961) Cancer Immuno-oncology Clinical Research and Trials Clinical Trial Results Hematological Cancers Leukemias Immunotherapy Cellular immunotherapy Engineered/CAR T cells |
| status_str | publishedVersion |
| title | Supplemental Figure S3 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL |
| title_full | Supplemental Figure S3 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL |
| title_fullStr | Supplemental Figure S3 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL |
| title_full_unstemmed | Supplemental Figure S3 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL |
| title_short | Supplemental Figure S3 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL |
| title_sort | Supplemental Figure S3 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL |
| topic | Cancer Immuno-oncology Clinical Research and Trials Clinical Trial Results Hematological Cancers Leukemias Immunotherapy Cellular immunotherapy Engineered/CAR T cells |